HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fenofibrate is effective in treating hypertriglyceridemia associated with HIV lipodystrophy.

AbstractOBJECTIVE:
To determine the effectiveness of fenofibrate in treating hypertriglyceridemia associated with highly active antiretroviral therapy-associated HIV lipodystrophy syndrome (HLS).
METHODS:
The authors recruited from their HIV metabolic clinic 55 adult patients with anthropomorphic changes consistent with HLS together with hypertriglyceridemia. The patients had no prior history of taking lipid-lowering medications and were free of liver and renal disease. They were on various highly active antiretroviral therapy regimens, and these regimens were not altered during the course of the study. Fenofibrate was started at 54 mg a day and the dose increased every 2 weeks to a maximum of 162 mg/day. Fasting lipid concentrations were measured at baseline and 6 months after the intervention.
RESULTS:
At baseline, the fasting plasma concentrations of total cholesterol, triglyceride, and high-density lipoprotein (HDL) cholesterol were 259 +/- 11, 886 +/- 172, and 35.7 +/- 2.3 (mean +/- SEM) mg/dL, respectively. After 6 months of fenofibrate treatment, the fasting plasma concentrations were as follows: total cholesterol, 243 +/- 13; triglycerides, 552 +/- 104, and HDL cholesterol, 35.7 +/- 1.8 mg/dL. The decrease in fasting plasma triglyceride concentration was statistically significant (P < 0.05). Fenofibrate was well tolerated, and no subjects dropped out of the study.
CONCLUSION:
Fenofibrate is an effective, well-tolerated treatment for hypertriglyceridemia associated with HLS.
AuthorsArchana Rao, Susana D'Amico, Ashok Balasubramanyam, Mario Maldonado
JournalThe American journal of the medical sciences (Am J Med Sci) Vol. 327 Issue 6 Pg. 315-8 (Jun 2004) ISSN: 0002-9629 [Print] United States
PMID15201643 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Fenofibrate
Topics
  • Adult
  • Female
  • Fenofibrate (therapeutic use)
  • HIV-Associated Lipodystrophy Syndrome (blood, complications, drug therapy)
  • Humans
  • Hypertriglyceridemia (blood, complications, drug therapy)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: